Different death rates between COVID-19 waves among unvaccinated patients: moving beyond lessons learned.
作者信息
Campagna Davide, Russo Crsitina, Trovato Elisa, Bridgeman Joseph, Polosa Riccardo
机构信息
Center of Excellence for the Acceleration of HArm Reduction (CoEHAR), University of Catania, Catania, Italy.
Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
出版信息
Intern Emerg Med. 2023 Jan;18(1):7-9. doi: 10.1007/s11739-022-03131-5. Epub 2022 Oct 22.
Abstract
摘要
相似文献
1
Different death rates between COVID-19 waves among unvaccinated patients: moving beyond lessons learned.未接种疫苗患者中新冠疫情不同波次间的死亡率差异：超越经验教训
Intern Emerg Med. 2023 Jan;18(1):7-9. doi: 10.1007/s11739-022-03131-5. Epub 2022 Oct 22.
2
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence - 25 U.S. Jurisdictions, April 4-December 25, 2021.COVID-19 发病率和死亡率在有和没有加强针的未接种和完全接种成年人中，在德尔塔和奥密克戎变体出现期间-25 个美国司法管辖区，2021 年 4 月 4 日至 12 月 25 日。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):132-138. doi: 10.15585/mmwr.mm7104e2.
3
Vaccines beyond antibodies: Spurred by pandemic research, are T-cell vaccines moving closer to reality?疫苗不止抗体：受疫情研究推动，T 细胞疫苗更趋现实？
EMBO Rep. 2021 Nov 4;22(11):e54073. doi: 10.15252/embr.202154073. Epub 2021 Oct 18.
4
Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study).匈牙利在德尔塔和奥密克戎流行期间首次和第二次 SARS-CoV2 加强疫苗的全国有效性（HUN-VE 2 研究）。
Front Immunol. 2022 Jun 23;13:905585. doi: 10.3389/fimmu.2022.905585. eCollection 2022.
5
Beyond prevention: Unveiling the benefits of triple vaccination on COVID-19 severity and resource utilization in solid organ transplant recipients.预防之外：揭示三联疫苗接种对实体器官移植受者新冠病毒疾病严重程度及资源利用的益处
Transpl Immunol. 2024 Jun;84:102048. doi: 10.1016/j.trim.2024.102048. Epub 2024 Apr 17.
6
Effect of mutation and vaccination on spread, severity, and mortality of COVID-19 disease.新冠病毒疾病的传播、严重程度和死亡率的突变和疫苗接种影响。
J Med Virol. 2022 Jan;94(1):197-204. doi: 10.1002/jmv.27293. Epub 2021 Aug 30.
7
Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.与未接种疫苗的患者相比，使用主要生物标志物比较感染 SARS-CoV-2 Delta 或 Omicron VOC 患者的疾病严重程度和同源疫苗接种效果。
J Med Virol. 2022 Dec;94(12):5867-5876. doi: 10.1002/jmv.28098. Epub 2022 Sep 9.
8
SARS-CoV-2 Infection and Death Rates Among Maintenance Dialysis Patients During Delta and Early Omicron Waves - United States, June 30, 2021-September 27, 2022.SARS-CoV-2 感染率和维持性透析患者死亡率在德尔塔和奥密克戎变异株早期流行期间-美国，2021 年 6 月 30 日-2022 年 9 月 27 日。
MMWR Morb Mortal Wkly Rep. 2023 Aug 11;72(32):871-876. doi: 10.15585/mmwr.mm7232a4.
9
Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged ≥65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months - 20 U.S. Jurisdictions, September 18, 2022-April 1, 2023.实地报告：2022年9月18日至2023年4月1日期间，美国20个司法管辖区内≥65岁未接种疫苗的成年人与在过去6个月内接种二价加强针的成年人的新冠死亡率比较
MMWR Morb Mortal Wkly Rep. 2023 Jun 16;72(24):667-669. doi: 10.15585/mmwr.mm7224a6.
10
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.COVID-19 病例和住院情况按 COVID-19 疫苗接种状况和既往 COVID-19 诊断情况划分-加利福尼亚州和纽约州，2021 年 5 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):125-131. doi: 10.15585/mmwr.mm7104e1.
引用本文的文献
1
Two years of SARS-CoV-2 pandemic and COVID-19 in Lombardy, Italy.意大利伦巴第大区两年的 SARS-CoV-2 大流行和 COVID-19 疫情。
Intern Emerg Med. 2023 Aug;18(5):1445-1451. doi: 10.1007/s11739-023-03315-7. Epub 2023 Jun 14.
本文引用的文献
1
The unseen pandemic: treatment delays and loss to follow-up due to fear of COVID.隐匿的大流行：因恐惧新冠而导致的治疗延误和失访
J Anesth Analg Crit Care. 2022 Jan 28;2(1):5. doi: 10.1186/s44158-021-00032-5.
2
Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials.肝素全剂量抗凝治疗住院非危重症 COVID-19 患者的疗效和安全性：多中心随机对照试验的荟萃分析。
J Thromb Thrombolysis. 2022 Oct;54(3):420-430. doi: 10.1007/s11239-022-02681-x. Epub 2022 Aug 3.
3
Comparison of the characteristics, morbidity and mortality of COVID-19 between first and second/third wave in a hospital setting in Lombardy: a retrospective cohort study.在伦巴第地区医院环境中比较第一波和第二/第三波 COVID-19 的特征、发病率和死亡率：一项回顾性队列研究。
Intern Emerg Med. 2022 Oct;17(7):1941-1949. doi: 10.1007/s11739-022-03034-5. Epub 2022 Jul 9.
4
Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline.更新于 2022 年 6 月：住院成人 2019 冠状病毒病（COVID-19）的管理：欧洲呼吸学会临床实践指南。
Eur Respir J. 2022 Aug 10;60(2). doi: 10.1183/13993003.00803-2022. Print 2022 Aug.
5
The effect of laboratory-verified smoking on SARS-CoV-2 infection: results from the Troina sero-epidemiological survey.实验室验证吸烟对 SARS-CoV-2 感染的影响：特罗伊纳血清流行病学调查结果。
Intern Emerg Med. 2022 Sep;17(6):1617-1630. doi: 10.1007/s11739-022-02975-1. Epub 2022 Apr 14.
6
The roles of methylprednisolone treatment in patients with COVID-19: A systematic review and meta-analysis.甲泼尼龙治疗 COVID-19 患者的作用：系统评价和荟萃分析。
Steroids. 2022 Jul;183:109022. doi: 10.1016/j.steroids.2022.109022. Epub 2022 Mar 26.
7
Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold.个体对 SARS-CoV-2 的易感性或暴露程度的差异降低了群体免疫阈值。
J Theor Biol. 2022 May 7;540:111063. doi: 10.1016/j.jtbi.2022.111063. Epub 2022 Feb 18.
8
Lower Rate of Daily Smokers With Symptomatic COVID-19: A Monocentric Self-Report of Smoking Habit Study.有症状的新冠肺炎每日吸烟者比例较低：一项吸烟习惯的单中心自我报告研究。
Front Med (Lausanne). 2022 Jan 5;8:668995. doi: 10.3389/fmed.2021.668995. eCollection 2021.
9
Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2.新冠病毒感染后与 SARS-CoV-2 疫苗接种的感染后免疫
Viral Immunol. 2021 Oct;34(8):504-509. doi: 10.1089/vim.2021.0054. Epub 2021 Jul 5.
10
Cytokine Storm.细胞因子风暴
N Engl J Med. 2020 Dec 3;383(23):2255-2273. doi: 10.1056/NEJMra2026131.
Zotero 插件